U.S. regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy. The Food and Drug Administration approved a 7.2-milligram dose of Novo Nordisk's semaglutide. Previously, the highest approved dose of the drug, taken as a …
You will be redirected in 10 seconds.